News

Clean Biologics, an international group providing services to the biopharmaceutical industry, appointed Laurent Claisse as ...
Ipsen, a global specialty care-driven biopharmaceutical company, has appointed Laura Réveillon, PhD as EVP, Strategy & ...
PCI Pharma Services has acquired Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO and subsidiary of Japan-based ...
VERAXA Biotech AG ( VERAXA) has entered a co-discovery alliance with OmniAb, Inc. for the development of a novel bispecific antibody drug conjugate (bsADC) program targeting solid tumors.
Aptar CSP Technologies, part of AptarGroup Inc., has expanded its service offerings with the launch of a cGMP-compliant ...
Following the acquisition of IFF Pharma Solutions, Roquette has created 2 complementary Business Groups: Health & Pharma ...
Formulation challenges can feel like roadblocks — from API incompatibility and dissolution delays to safety concerns and ...
Matica Biotechnology, a specialized CDMO for cell and gene therapies, has partnered with the National Center for Therapeutics ...
Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common stock, plus one non-tradeable contingent ...
Bristol Myers Squibb plans to close its viral vector production facility in Libertyville, IL according to a BMS spokesperson ...
Merck has initiated construction of a $1 billion, 470,000-square-foot biologics center of excellence in Wilmington, Delaware.